DH logo

Definitive Healthcare (DH)

Profile

Full Name

Definitive Healthcare Corp.

Ticker Symbol

DH

Exchange

NASDAQ

Sector

Healthcare

Industry

Health Information Services

Country

United States

IPO

September 15, 2021

Indexes

Not included

Website

http://www.definitivehc.com

Employees

782

Key Details

Price

$2.53(+1.20%)

Market cap

$285.67M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$252.20M(+0.31% YoY)

Annual EPS

-$3.54(-97.77% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.53
DH price is $2.53

30-Day Relative Volume

0.44
DH 30-day relative volume is 0.44

Price Performance

Price Most recent change

+1.2%
DH price was up +1.2% on Apr 16, 2025

Price YTD change

-38.44%
DH price is down -38.44% since January 1st

Price 1-year change

-65.39%
DH price is down -65.39% year-on-year

Price 3-year change

-89.88%
DH price is down -89.88% over the past 3 years

Price Range

Price All-time high

$50.30
DH price is currently -94.97% below its historical high of $50.30

Price 3-year low

$2.15
DH price is currently +17.67% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$285.67M
DH market capitalization is $285.67 million

Market cap 3-year change

-88.29%
DH market capitalization is down -88.29% over the past 3 years

Market cap All-time high

$4.32B
DH market capitalization is currently -93.39% below its historical high of $4.32 billion

Market cap sector rank

62.66%
DH market capitalization is higher than 62.66% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-4.14%
DH shares outstanding is down -4.14% year-on-year

Shares Outstanding 3-Year Change

+15.72%
DH shares outstanding is up +15.72% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.70
DH beta is 0.70

200-day SMA

$4.27
DH price is currently -40.76% below its 200-day simple moving average

50-day SMA

$3.51
DH price is currently -27.97% below its 50-day simple moving average

RSI

36.27
DH 14-day relative strength index is 36.27

Volume

0.44
DH 30-day relative volume is 0.44

ATR

$0.20
DH average true range is $0.20

10-day Historical Volatility

60.98%
DH 10-day historical volatility is 60.98%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$252.20M
DH annual revenue is $252.20 million

Revenue Analysts estimate

$234.24M
DH annual revenue is currently +7.67% higher than the consensus analysts' forecast

Revenue 1-year change

+0.31%
DH annual revenue is up +0.31% year-on-year

Revenue Sector rank

66.7%
DH annual revenue is higher than 66.7% of companies in Healthcare sector

EPS

EPS

-$3.54
DH annual earnings per share is -$3.54

EPS Analysts estimate

$0.21
DH annual earnings per share is currently -1765.10% lower than the consensus analysts' forecast

EPS 1-year change

-97.77%
DH annual earnings per share is down -97.77% year-on-year

EPS Sector rank

25.52%
DH annual earnings per share is higher than 25.52% of companies in Healthcare sector

Profit

Gross profit

$197.47M
DH annual gross profit is $197.47 million

Gross margin

78.30%
DH annual gross profit margin is 78.30%

Operating profit

-$9.74M
DH annual operating income is -$9.74 million

Operating margin

-3.86%
DH annual operating profit margin is -3.86%

Net income

-$413.12M
DH annual net profit is -$413.12 million

Net margin

-163.81%
DH annual net profit margin is -163.81%

Expenses

Total expenses

$261.94M
DH annual total expenses is $261.94 million

Operating expenses

$207.21M
DH annual total operating expenses is $207.21 million

Cost of goods sold

$54.73M
DH annual cost of goods sold is $54.73 million

Selling, general & administrative expenses

$133.07M
DH annual SGA is $133.07 million

Depreciation and amortization

$51.67M
DH annual depreciation & amortization is $51.67 million

Interest expense

$14.84M
DH annual interest expense is $14.84 million

Income tax

-$42.30M
DH annual income tax is -$42.30 million

EBIT & EBITDA

EBIT

-$618.91M
DH annual earnings before interest & taxes is -$618.91 million

EBITDA

-$567.24M
DH annual EBITDA is -$567.24 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.09B
DH annual total assets is $1.09 billion

Non current assets

$719.22M
DH annual long term assets is $719.22 million

Current assets

$370.17M
DH annual total current assets is $370.17 million

Cash and cash equivalents

$105.38M
DH annual cash & cash equivalents is $105.38 million

Accounts receivable

$54.62M
DH annual accounts receivable is $54.62 million

Inventory

-
DH annual inventory value is unknown

Liabilities

Total liabilities

$482.19M
DH annual total liabilities is $482.19 million

Long term liabilities

$321.03M
DH annual total long term liabilities is $321.03 million

Current liabilities

$161.16M
DH annual total current liabilities is $161.16 million

Accounts payable

$10.76M
DH annual accounts payable is $10.76 million

Debt

Total debt

$253.11M
DH annual total debt is $253.11 million

Total debt 1-year change

-5.53%
DH annual total debt is down -5.53% year-on-year

Long term debt

$236.95M
DH annual long term debt is $236.95 million

Short term debt

$16.16M
DH annual short term debt is $16.16 million

Equity & Capital

Shareholders equity

$444.38M
DH annual stockholders equity is $444.38 million

Book value

$444.38M
DH annual book value is $444.38 million

Retained earnings

-$640.57M
DH annual retained earnings is -$640.57 million

Working capital

$209.01M
DH annual working capital is $209.01 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$58.20M
DH annual cash flow from operations is $58.20 million

Cash from operations 1-year change

+41.29%
DH annual cash flow from operations is up +41.29% year-on-year

Cash from investing

-$26.41M
DH annual cash flow from investing activities is -$26.41 million

Cash from investing 1-year change

+16.91%
DH annual cash flow from investing activities is up +16.91% year-on-year

Cash from financing

-$56.75M
DH annual cash flow from financing activities is -$56.75 million

Cash from financing 1-year change

-121.81%
DH annual cash flow from financing activities is down -121.81% year-on-year

CAPEX

CAPEX

$12.34M
DH annual capital expenditures is $12.34 million

CAPEX 1-year change

+314.65%
DH annual capital expenditures is up +314.65% year-on-year

Free Cash Flow

Free cash flow

$45.85M
DH annual free cash flow is $45.85 million

Free cash flow 1-year change

+19.99%
DH annual free cash flow is up +19.99% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

78.30%
DH annual gross profit margin is 78.30%

Operating margin

-3.86%
DH annual operating profit margin is -3.86%

Net margin

-163.81%
DH annual net profit margin is -163.81%

ROA & ROE

ROA

-28.34%
DH annual return on assets is -28.34%

ROE

-45.74%
DH annual return on equity is -45.74%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
DH price to earnings ratio value is unknown

PE ratio Sector rank

-
DH price to earnings ratio is unknown

PB Ratio

PB ratio

0.64
DH price to book ratio is 0.64

PB ratio Sector rank

34.65%
DH price to book ratio is higher than 34.65% of companies in Healthcare sector

PS Ratio

PS ratio

1.13
DH price to sales ratio is 1.13

PS ratio Sector rank

30%
DH price to sales ratio is higher than 30% of companies in Healthcare sector

Enterprise value

Enterprise value

$433.40M
DH enterprise value is $433.40 million

Enterprise value Sector rank

67.91%
DH enterprise value is higher than 67.91% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.76
DH EV/EBITDA is -0.76

EV/EBITDA Sector rank

46.82%
DH EV/EBITDA is higher than 46.82% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.30
DH annual current ratio is 2.30

Quick ratio

-
DH annual quick ratio value is unknown

Leverage

Debt to equity

0.55
DH annual debt to equity ratio is 0.55

Interest coverage ratio

-41.71
DH annual interest coverage ratio is -41.71

Risk & Stability

Piotroski F-Score

5
DH piotroski f-score is 5

Altman Z-Score

-1.88
DH altman z-score is -1.88

Analyst ratings

Recent major analysts updates

Mar 4, 25 Goldman Sachs
Neutral
Mar 3, 25 Barclays
Underweight
Jan 16, 25 Needham
Hold
Jan 13, 25 Barclays
Underweight
Dec 20, 24 Stephens & Co.
Equal-Weight
Nov 8, 24 Needham
Hold
Sep 17, 24 BTIG
Buy
Aug 9, 24 Deutsche Bank
Hold
Aug 7, 24 Barclays
Equal-Weight
Aug 7, 24 Baird
Neutral

Institutional Ownership

Similar stocks

NNOX logo
Nano-X Imaging (NNOX)
ATAI logo
Atai Life Sciences NV (ATAI)
PSNL logo
Personalis (PSNL)
HRTX logo
Heron Therapeutics (HRTX)
OLMA logo
Olema Pharmaceuticals (OLMA)
Anbio Biotechnology Class A (NNNN)
ARCT logo
Arcturus Therapeutics Holdings (ARCT)
PHAT logo
Phathom Pharmaceuticals (PHAT)
CMPS logo
COMPASS Pathways (CMPS)
  • What is the ticker symbol for Definitive Healthcare?
  • Does Definitive Healthcare pay dividends?
  • What sector is Definitive Healthcare in?
  • What industry is Definitive Healthcare in?
  • What country is Definitive Healthcare based in?
  • When did Definitive Healthcare go public?
  • Is Definitive Healthcare in the S&P 500?
  • Is Definitive Healthcare in the NASDAQ 100?
  • Is Definitive Healthcare in the Dow Jones?
  • When was Definitive Healthcare's last earnings report?
  • When does Definitive Healthcare report earnings?
  • Should I buy Definitive Healthcare stock now?

What is the ticker symbol for Definitive Healthcare?

The ticker symbol for Definitive Healthcare is NASDAQ:DH

Does Definitive Healthcare pay dividends?

No, Definitive Healthcare does not pay dividends

What sector is Definitive Healthcare in?

Definitive Healthcare is in the Healthcare sector

What industry is Definitive Healthcare in?

Definitive Healthcare is in the Health Information Services industry

What country is Definitive Healthcare based in?

Definitive Healthcare is headquartered in United States

When did Definitive Healthcare go public?

Definitive Healthcare's initial public offering (IPO) was on September 15, 2021

Is Definitive Healthcare in the S&P 500?

No, Definitive Healthcare is not included in the S&P 500 index

Is Definitive Healthcare in the NASDAQ 100?

No, Definitive Healthcare is not included in the NASDAQ 100 index

Is Definitive Healthcare in the Dow Jones?

No, Definitive Healthcare is not included in the Dow Jones index

When was Definitive Healthcare's last earnings report?

Definitive Healthcare's most recent earnings report was on Feb 27, 2025

When does Definitive Healthcare report earnings?

The next expected earnings date for Definitive Healthcare is May 7, 2025

Should I buy Definitive Healthcare stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page